Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 7, 2012; 18(17): 2092-2098
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2092
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2092
Group A | Group B | |
Day 1 | ||
Three regular meals | Low fiber diet | Low fiber diet |
Evening (7-9 pm) | - | 2 L PEG-ELS |
Bedtime | 24 mg sennoside | 24 mg sennoside |
Day 01 | ||
1st Step | 100 mL water including 1 g pronase and 2.5 g sodium bicarbonate | 100 mL water including 1 g pronase and 2.5 g sodium bicarbonate |
2nd Step | 15 mg mosapride | 15 mg mosapride |
3rd Step | 2 L PEG-ELS with 400 mg dimethicone | 1 L PEG-ELS with 400 mg dimethicone |
4th Step2 | Additional 300 mL PEG-ELS | Additional 300 mL PEG-ELS |
Maximum, administered twice: Maximum dosage 600 mL | Maximum, administered twice: Maximum dosage 600 mL | |
0 h | Colon capsule ingestion | Colon capsule ingestion |
2 h (BoosterI3 ) | 50 g magnesium citrate/900 mL water | 50 g magnesium citrate/900 mL water |
6 h (Booster II) | 50 g magnesium citrate/900 mL water | 50 g magnesium citrate/900 mL water |
7 h | 5 mg mosapride | 5 mg mosapride |
- Citation: Kakugawa Y, Saito Y, Saito S, Watanabe K, Ohmiya N, Murano M, Oka S, Arakawa T, Goto H, Higuchi K, Tanaka S, Ishikawa H, Tajiri H. New reduced volume preparation regimen in colon capsule endoscopy. World J Gastroenterol 2012; 18(17): 2092-2098
- URL: https://www.wjgnet.com/1007-9327/full/v18/i17/2092.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i17.2092